Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin.

Autor: Heiblig M; Hematology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Gourguechon C; Department of Hematology, Amiens University Hospital, Amiens, France., Guilpain P; CEREMAST, the Department of Internal Medicine-Multi-organ Diseases, Saint-Eloi University Hospital, Montpellier University, Montpellier, France., Bulai-Livideanu C; CEREMAST Toulouse, Dermatology Departmen, CHU de Toulouse, Toulouse, France., Barete S; Sorbonne Université, APHP, Unité Fonctionnelle de Dermatologie, Groupe Hospitalier Pitié-Salpêtrière-C. Foix, Paris, France.; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France., Chantran Y; Department of Biological Hematology, Pitié-Salpêtrière Hospital, DMU BioGem, AP-HP, Sorbonne University, Paris, France.; Department of Biological Immunology, Saint-Antoine Hospital, DMU BioGem, AP-HP, Sorbonne University, Paris, France.; Health Environmental Risk Assessment (HERA) Team, Centre of Research in Epidemiology and Statistics (CRESS), Inserm/INRAE, Faculty of Pharmacy, Université de Paris, Paris, France., Agopian J; Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytoses (AFIRMM), Paris, France., Brenet F; Centre de Recherche en Cancérologie de Marseille (CRCM) INSERM U1068, CNRS UMR7258, AMU U105, Département d'Onco-Hématologie-Immunologie, Institut Paoli-Calmettes, Marseille, France., Dubreuil P; Centre de Recherche en Cancérologie de Marseille (CRCM) INSERM U1068, CNRS UMR7258, AMU U105, Département d'Onco-Hématologie-Immunologie, Institut Paoli-Calmettes, Marseille, France., Lespinasse J; eXYSTAT, Malakoff, France., Lemal R; Adult Clinical Hematology, Clermont-Ferrand University Hospital, INSERM CIC501, EA 7453-Université Clermont Auvergne, Clermont-Ferrand, France., Tournilhac O; Adult Clinical Hematology, Clermont-Ferrand University Hospital, INSERM CIC501, EA 7453-Université Clermont Auvergne, Clermont-Ferrand, France., Terriou L; INSERM, CHU Lille, Department of Internal Medicine and Clinical Immunology, U1286 - INFINITE - Institute for Translational Research in Inflammation, University Lille, Lille, France., Launay D; INSERM, CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, University Lille, Lille, France., Bouillet L; Internal Medicine Department, Grenoble Alpes University Hospital, Univ. Grenoble Alpes, T-RAIG unit, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, CHU Grenoble Alpes, TIMC, Grenoble, France., Chatain C; Internal Medicine Department, Grenoble Alpes University Hospital, Univ. Grenoble Alpes, T-RAIG unit, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, CHU Grenoble Alpes, TIMC, Grenoble, France., Damaj G; Haematology Institute, Normandy University School of Medicine, Caen, France., Ballul T; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.; Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France., Greco C; CEREMAST, the Department of Pain and Palliative Care Unit, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Polivka L; Haematology Institute, Normandy University School of Medicine, Caen, France.; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Cité University, Paris, France.; CEREMAST, the Department of Hematology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Frenzel L; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.; Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France., Meni C; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France., Bouktit H; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France., Benabou D; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France., Gaudy-Marqueste C; Dermatology and Skin Cancer, Department, Aix-Marseille University, APHM, Marseille, France., Gousseff M; Department of Internal Medicine, Bretagne Atlantique Hospital, Vannes, France., Le Mouel E; Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France., Neel A; CEREMAST, the Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes, France., Ranta D; Department of Haematology, Nancy University Hospital, Nancy, France., Jaussaud R; Department of Internal Medicine and Clinical Immunology, Vandoeuvre-lès-Nancy, France., Molina TJ; Department of pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Bruneau J; Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France.; Department of pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Villarese P; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Lhermitte L; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; CNRS, INSERM U1151, Institut Necker Enfants Malades (INEM), Université Paris Cité, Paris, France., Maouche-Chrétien L; Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France., Temple M; Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.; INSERM U1016, Université de Paris, Institut Cochin, Paris, France., Kosmider O; Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.; INSERM U1016, Université de Paris, Institut Cochin, Paris, France., Javier RM; Rheumatology Department, Competence Center for Rare Genetic Bone Disorders, University-Hospital of Strasbourg, Strasbourg, France., Pelletier F; CEREMAST, the Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon, France., Castelain F; Unité Transversale Allergologie, Dermatologie, CHU Besançon - Université de Franche-Comté, EFS, INSERM, UMR RIGHT, Besançon, France., Retornaz F; Unité de soins et de recherche en médecine interne et maladies infectieuses, European Hospital, Marseille, France., Cabrera Q; Department of Haematology, Sud Reunion University Hospital, Saint Pierre, France., Zunic P; Department of Haematology, Sud Reunion University Hospital, Saint Pierre, France., Gourin MP; CEREMAST, the Department of Hematology, CHU Dupuytren, Limoges, France., Wierzbicka-Hainaut E; CEREMAST, the Department of Dermatology, CHU de Poitiers, Poitiers, France., Viallard JF; Department of Internal Medicine, Hôpital Haut-Lévêque, Université de BORDEAUX, Pessac, France., Lavigne C; Department of Internal Medicine, Angers University Hospital, Angers, France., Hoarau C; The Service d'Immunologie Clinique et d'Allergologie, Centre Hospitalier Régional Universitaire, Tours, France., Durieu I; Internal Medicine Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.; INSERM U1290, Université Lyon 1, Lyon, France., Dimicoli-Salazar S; Department of Hematology, CHU de Bordeaux, Bordeaux, France., Torregrosa-Diaz JM; Service d'hématologie Oncologique et Thérapie Cellulaire, CIC-1402, CHU de Poitiers, Poitiers, France., Wemeau M; Department of Haematology, Hospital Centre of Roubaix, Roubaix, France., Soria A; Department of Dermatology and Allergy, Tenon Hospital, Sorbonne University, Paris, France., Arock M; Platform of Molecular Analysis for Mastocytosis and MCAD (CEREMAST), Department of Biological Hematology, Pitié-Salpêtrière Hospital, AP-HP, Paris Sorbonne University, Paris, France., Bodemer C; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Cité University, Paris, France.; CEREMAST, the Department of Hematology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Lortholary O; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France., Hermine O; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.; CEREMAST, the Department of Pain and Palliative Care Unit, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Rossignol J; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.; Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Nov; Vol. 99 (11), pp. 2127-2139. Date of Electronic Publication: 2024 Sep 17.

Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis.

Autor: Rossignol J; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris., Georgin-Lavialle S; Department of Internal Medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris., Canioni D; CEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris., Beganovic O; Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris., Brouzes C; Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris., Fain O; Department of Internal Medicine, Sorbonne University, Saint-Antoine Hospital, AP-HP, Paris., Heiblig M; CEREMAST, Department of Hematology, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite., Gourguechon C; Department of Hematology, Amiens University Hospital, Amiens., Guilpain P; CEREMAST, Department of Internal Medicine-Multi-organ Diseases, Saint-Eloi University Hospital, Montpellier University, Montpellier., Bulai-Livideanu C; CEREMAST, Department of Dermatology, Hôpital Larrey, CHU Toulouse, Toulouse., Barete S; CEREMAST, Dermatology Department, Pitié-Salpêtrière Hospital, AP-HP, Paris., Agopian J; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille., Brenet F; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille., Dubreuil P; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille., Lemal R; CEREMAST, Adult Clinical Hematology, CHU Clermont-Ferrand, INSERM CIC501, EA 7453 - Clermont Auvergne University, Clermont-Ferrand., Tournilhac O; CEREMAST, Adult Clinical Hematology, CHU Clermont-Ferrand, INSERM CIC501, EA 7453 - Clermont Auvergne University, Clermont-Ferrand., Terriou L; CEREMAST, Department of Internal Medicine and Clinical Immunology, Claude Huriez hospital, CHRU Lille, Lille., Launay D; CEREMAST, Department of Internal Medicine and Clinical Immunology, Claude Huriez hospital, CHRU Lille, Lille, France; Lille University, INSERM U995 LIRIC, CHU Lille, and Referral Center for Rare Systemic Autoimmune Diseases North and North-West of France, Lille., Bouillet L; CEREMAST, Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble., Chatain C; CEREMAST, Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble., Damaj G; CEREMAST, Hematology Institute, Normandy University School of Medicine, Caen., Ballul T; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris., Greco C; CEREMAST, Department of Pain and Palliative Care Unit, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris., Polivka L; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), AP-HP, Necker-Children's Hospital, Paris Centre University, Paris., Frenzel L; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris., Meni C; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris., Bouktit H; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris., Benabou D; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris., Devin C; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris., Gaudy-Marqueste C; CEREMAST, Department of Dermatology, Aix-Marseille University, CHU Timone, Marseille., Gousseff M; Department of Internal Medicine, Centre Hospitalier Bretagne Atlantique, Vannes., Le Mouel E; CEREMAST, Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes., Neel A; CEREMAST, Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes., Ranta D; Department of Hematology, Nancy University Hospital, Nancy., Jaussaud R; Department of Internal Medicine and Clinical Immunology, Vandoeuvre-lès-Nancy., Jo Molina T; CEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris., Bruneau J; CEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris., Javier RM; CEREMAST, Department of Rheumatology, Strasbourg University Hospital, Strasbourg., Pelletier F; CEREMAST, Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon., Castelain F; CEREMAST, Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon., Retornaz F; Unité de soins et de recherche en médecine interne et maladies infectieuses, European hospital, Marseille., Cabrera Q; Department of Hematology, Sud Reunion University Hospital, Saint Pierre, La Réunion., Zunic P; Department of Hematology, Sud Reunion University Hospital, Saint Pierre, La Réunion., Gourin MP; CEREMAST, Department of Hematology, CHU Dupuytren, Limoges., Wierzbicka-Hainaut E; CEREMAST, Department of Dermatology, CHU de Poitiers, Poitiers., Viallard JF; Department of Internal Medicine and Infectious Diseases, Haut-Lévêque Hospital, CHRU Bordeaux; Bordeaux University, Bordeaux., Lavigne C; CEREMAST, Department of Internal Medicine and Clinical Immunology, University Hospital, Angers., Hoarau C; CEREMAST, Department of Clinical Immunology and Allergology, CHRU Tours, Tours., Durieu I; CEREMAST, Department of Internal Medicine, Adult Cystic Fibrosis Care Center, Hospices Civils de Lyon, Lyon., Dimicoli-Salazar S; Department of Hematology, CHU Bordeaux, Bordeaux., Torregrosa-Diaz JM; Department of Hematology, CHU Poitiers, Poitiers., Duval A; Paris Centre University, Imagine Institute, Data Science Platform, INSERM UMR 1163, F-75015, Paris., Garcelon N; Paris Centre University, Imagine Institute, Data Science Platform, INSERM UMR 1163, F-75015, Paris., Lespinasse J; eXYSTAT, Malakoff., Soria A; CEREMAST, Department of Dermatology and Allergy, Tenon Hospital, Sorbonne University, Paris., Chantran Y; CEREMAST, Department of Biological Immunology, Saint-Antoine Hospital, Sorbonne University, Paris., Arock M; CEREMAST, Laboratory of Hematology, Pitié-Salpêtrière Hospital, AP-HP, Paris Sorbonne University., Bodemer C; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), AP-HP, Necker-Children's Hospital, Paris Centre University, Paris., Lortholary O; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris., Asnafi V; Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris., Hermine O; CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris., Lhermitte L; Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris. ludovic.lhermitte@aphp.fr.

Publikováno v: Haematologica [Haematologica] 2024 Aug 29. Date of Electronic Publication: 2024 Aug 29.

Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.

Autor: Carras S; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Molecular biology department; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Oncohematology department., Torroja A; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Oncohematology department., Emadali A; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Research and innovation unit., Montaut E; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Research and innovation unit., Daguindau N; Hematology Department Annecy hospital., Tempescul A; Hematology Unit, Brest University Hospital, Brest France., Moreau A; Pathology Department, University Hospital, Nantes., Tchernonog E; Hematology Department, University Hospital, Montpellier., Schmitt A; Hematology Department, Cancerology Institute Bergonie, Bordeaux., Houot R; Hematology Department, University Hospital, Rennes., Dartigeas C; Hematology Department, University Hospital, Tours., Barbieux S; Hematology Department, Dunkerque Hospital., Corm S; Hematology Department, Chambery., Banos A; Hematology Department, Bayonne Cote Basque Hospital., Fouillet L; Hematology Department, University Hospital, Saint Etienne., Dupuis J; Lymphoid malignancies Unit, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Créteil., Macro M; IHBN - Hematology Department, University Hospital, Caen., Fleury J; Hematology Department, Cancerology Institute, Clermont-Ferrand., Jardin F; Hematology Department, Centre Henri Becquerel, Rouen., Sarkozy C; Institut Curie, Paris and Paris Saint Quentin University, UVSQ., Damaj G; Hematology Department, University Hospital, Caen., Feugier P; Hematology Department, University Hospital, Nancy., Fornecker LM; Hematology Department, University Hospital, Strasbourg., Chabrot C; Hematology Department, University Hospital, Clermont-Ferrand., Dorvaux V; Hematology Department, University Hospital, Metz., Bouabdallah K; Hematology Department, University Hospital, Bordeaux, Bordeaux., Amorim S; Hematology and cellular therapy Department, Hospital Saint Vincent de Paul, Université catholique de Lille., Garidi R; Hematology Department, Hospital Saint Quentin., Voillat L; Hematology Department, Hospital Chalon sur Saone., Joly B; Hematology Department, Corbeil Hospital., Morineau N; Hematology department, Hospital La Roche Sur Yon., Moles MP; Hematology Department, University Hospital Angers., Zerazhi H; Hematology Department, Avignon Hospital., Fontan J; Hematology Department, University Hospital, Besançon., Arkam Y; Hematology Department, Mulhouse Hospital., Alexis M; Hematology Department, Orleans Hospital., Delwail V; Onco-Hematology Department, University Hospital Poitiers and INSERM, CIC 1402, University of Poitiers., Vilque JP; Hematology Department, Cancer Center Baclesse Caen., Ysebaert L; Institut universitaire du cancer de Toulouse Oncopole., Burroni B; Assistance Publique - Hôpitaux de Paris (APHP), Hôpital Cochin, Department of Pathology; Centre de Recherche des Cordeliers, Sorbonne University, Inserm, UMRS 1138, Université Paris Cité, F-75006 Paris., Callanan M; Unit For Innovation in Genetics and Epigenetics and Oncology. Dijon University Hospital., Le Gouill S; Institut Curie, Paris and Paris Saint Quentin University, UVSQ., Gressin R; Univ. Grenoble Alpes. University Hospital, Grenoble France, Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309, UGA), Oncohematology department.

Publikováno v: Haematologica [Haematologica] 2024 Jun 01; Vol. 109 (6), pp. 1857-1865. Date of Electronic Publication: 2024 Jun 01.

A review of scaphoid fracture, treatment outcomes, and consequences.

Autor: Almigdad A; Department of Hand and Upper Limb Surgery, Department of Orthopedic, King Hussein Medical City, King Abdullah II St, Amman, 230, Jordan. akmigdad_just@yahoo.com., Al-Zoubi A; Department of Hand and Upper Limb Surgery, Department of Orthopedic, King Hussein Medical City, King Abdullah II St, Amman, 230, Jordan., Mustafa A; Department of Hand and Upper Limb Surgery, Department of Orthopedic, King Hussein Medical City, King Abdullah II St, Amman, 230, Jordan., Al-Qasaimeh M; Department of Hand and Upper Limb Surgery, Department of Orthopedic, King Hussein Medical City, King Abdullah II St, Amman, 230, Jordan., Azzam E; Department of Hand and Upper Limb Surgery, Department of Orthopedic, King Hussein Medical City, King Abdullah II St, Amman, 230, Jordan., Mestarihi S; Department of Hand and Upper Limb Surgery, Department of Orthopedic, King Hussein Medical City, King Abdullah II St, Amman, 230, Jordan., Khair Y; Department of Hand and Upper Limb Surgery, Department of Orthopedic, King Hussein Medical City, King Abdullah II St, Amman, 230, Jordan., Almanasier G; Department of Hand and Upper Limb Surgery, Department of Orthopedic, King Hussein Medical City, King Abdullah II St, Amman, 230, Jordan.

Publikováno v: International orthopaedics [Int Orthop] 2024 Feb; Vol. 48 (2), pp. 529-536. Date of Electronic Publication: 2023 Oct 26.